Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
97,996,626
-
Number of holders
-
15
-
Total 13F shares, excl. options
-
1,727,317
-
Shares change
-
+1,196,940
-
Total reported value, excl. options
-
$6,046,000
-
Value change
-
+$4,183,916
-
Number of buys
-
10
-
Number of sells
-
-5
-
Price
-
$3.50
Significant Holders of aTYR PHARMA INC - COMMON STOCK (ATYR) as of Q3 2019
15 filings reported holding ATYR - aTYR PHARMA INC - COMMON STOCK as of Q3 2019.
aTYR PHARMA INC - COMMON STOCK (ATYR) has 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,727,317 shares
of 97,996,626 outstanding shares and own 1.8% of the company stock.
Largest 10 shareholders include FEDERATED INVESTORS INC /PA/ (550,000 shares), FMR LLC (491,449 shares), VIKING GLOBAL INVESTORS LP (229,283 shares), RENAISSANCE TECHNOLOGIES LLC (193,620 shares), VANGUARD GROUP INC (166,483 shares), ACADIAN ASSET MANAGEMENT LLC (30,576 shares), GEODE CAPITAL MANAGEMENT, LLC (13,040 shares), Glen Harbor Capital Management LLC (10,914 shares), Meadow Creek Investment Management LLC (8,988 shares), and BlackRock Inc. (8,552 shares).
This table shows the top 15 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.